Debra Chipman retweeted
Catch up with the discussion on demand!
@HGlorikian hosted speakers from the likes of @NovartisScience, @abbvie , @GSK @transcelerate , @bmsnews and more to discuss, debate and share knowledge on AI Case Studies in Discovery & Clinical Developments: ow.ly/nJlY50C7dKa
Debra Chipman retweeted
Taking place on Monday -
Digital event: AI Case Studies in Discovery & Clinical Development
View the agenda and register now: ow.ly/Yjyo50BKWUB
Debra Chipman retweeted
Our upcoming digital experience is your unique opportunity to be among the right people at the right time for open conversations.
With insightful and practical takeaways you can bring back to your team, this is not one to miss, register today!
ow.ly/bnlC50BKVrL
Debra Chipman retweeted
Time is running out to register for our upcoming digital summit!
Don’t miss out on your unique opportunity to be among the right people at the right time for open conversations and to ask your burning questions.
Click to register & view the speaker list: ow.ly/gIcn50B3GCC
Debra Chipman retweeted
We’re showcasing the very best #AIApplicationsSummit content in a new digital format. Join us for the same high quality-content, connections and real-time engagement our community has come to expect from AI in Biopharma during this 2.5-hour event.
ow.ly/ZzUV50B3Gsk
Debra Chipman retweeted
Registration is now open!
Join us for our next webinar: Biopharma Data Management Strategies to Effectively Use AI Tools, with @HGlorikian, @PeterPitts and more!
Click here to view the agenda and secure your place: ow.ly/4xB450B3FQ5
Debra Chipman retweeted
Catch up with the discussion on demand and join Harry Glorikian, Niven Narain (@berg LLC), Andrew Radin (@twoXAR Pharmaceuticals), Mark Borowsky (@Novartis (NIBR)) and Christian Baber, Ph.D. (@takeda) as they discuss the power of data and AI/ML: ow.ly/mKQ150AAdq1
Debra Chipman retweeted
Missed our last webinar? Don’t worry, Making AI/ML Tools Scalable Across the Drug Development Lifecycle to Impact Patients is available to view now!
Access the webinar insights and discover the key learnings on data and AI/ML here: ow.ly/CsQN50AAdae
Debra Chipman retweeted
LAST CHANCE: Our webinar on Making AI/ML Tools Scalable Across The Drug Development Lifecycle to Impact Patients with @HGlorikian, @Niven_Narain, @andrew_radin, Mark Borowsky and Christian Baber takes place tomorrow at 10:30 am EDT.
Secure your place: ow.ly/lHWq50Am1Fi
Debra Chipman retweeted
Join me and our panelists @HGlorikian @Niven_Narain as we discuss effective use of AI in R&D on July 14 bigmarker.com/ai-inbiopharma…
Debra Chipman retweeted
Reminder: Webinar on Leveraging RWE + Advanced Analytics: The Need for a Modernized Drug Development Model in a Pandemic with @HGlorikian Ülo Palm (@Allergan), Thomas Bock, and @lixia_wang (@InterceptPharma) is this Friday at 1pm EDT.
Register here: ow.ly/u4IM50zyB9i
Debra Chipman retweeted
We are proud to announce that clinical stage biopharmaceutical company, Berg (@BergHealth) are sponsoring the #AIApplicationsSummit 2020!
Interested in sponsoring? Learn more here: ow.ly/WQG550zf3sb
Debra Chipman retweeted
For those who wanted a world without vaccines, witness the world without one vaccine.
Debra Chipman retweeted
Brittany and I are committing $5,000,000 to the State of Louisiana in 2020. The priority now is helping our communities get through this tough time.
After considerable research and conversations with local… instagram.com/p/B-M7SeCnIcP/…
Debra Chipman retweeted
Joshua Murphy (@ConcertoHlthAI) moderates as @DataHippie (@pfizer) and @VitalyDoban (@Novartis) speak about "Finding the Intersections Between #AI and #RWE to Better Treat Patients" #AIApplicationsSummit
Debra Chipman retweeted
T-30 minutes until Kate Hilyard (COO) takes to the @AIBioSummit stage. Join her and panellists to explore how #AI is being applied effectively to the #drugdiscovery process.
More info: lnkd.in/g7BEKJU #rarediseases
Debra Chipman retweeted
In a week when our new Boston HQ is launched, we are proud to sponsor the @AIBioSummit. Come see Nora Khaldi speak this afternoon at the Innovation Changemaker Presentations. Our new Chief Corporate Development Officer Arthur Hiller will also be attending.

























